Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
TORONTO, ONTARIO--(Marketwired - Jan. 21, 2016) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM)(OTCQX:HMTXF), a clinical-stage autologous cell-therapy company,...
-
TORONTO, ONTARIO--(Marketwired - Jan. 21, 2016) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM)(OTCQX:HMTXF), a clinical-stage autologous cell-therapy company,...
-
TORONTO, ONTARIO--(Marketwired - Dec. 28, 2015) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM)(OTCQX:HMTXF), a clinical-stage autologous cell-therapy company,...
-
TORONTO, ONTARIO--(Marketwired - Dec. 22, 2015) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM), a clinical-stage autologous cell-therapy company, announced today the...
-
TORONTO, ONTARIO--(Marketwired - Dec. 2, 2015) - NOT FOR DISSEMINATION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Hemostemix Inc. ("Hemostemix" or...
-
TORONTO, ONTARIO--(Marketwired - Nov. 30, 2015) - NOT FOR DISSEMINATION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Hemostemix Inc. ("Hemostemix" or...
-
TORONTO, ONTARIO--(Marketwired - Nov. 5, 2015) - NOT FOR DISSEMINATION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Hemostemix Inc. ("Hemostemix" or...
-
TORONTO, ONTARIO--(Marketwired - Oct. 26, 2015) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM), a clinical-stage autologous cell-therapy company, announced today the...
-
TORONTO, ONTARIO--(Marketwired - Oct. 8, 2015) - NOT FOR DISSEMINATION TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Hemostemix Inc. ("Hemostemix" or...
-
TORONTO, ONTARIO--(Marketwired - Oct. 5, 2015) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM), a clinical-stage autologous cell-therapy company, announced today that...